Orla/iStock via Getty Images I never find pleasure in taking a bearish stance on a company. In a perfect world, every company would be a thriving success story. Unfortunately, that's not reality. That's why, back in February of this year, I had to make the difficult choice to downgrade Clarus Corporation ( CLAR ) from a "Hold" to a "Sell." This was because of ongoing financial pressure that the co...
Orla/iStock via Getty Images I never find pleasure in taking a bearish stance on a company. In a perfect world, every company would be a thriving success story. Unfortunately, that's not reality. That's why, back in February of this year, I had to make the difficult choice to downgrade Clarus Corporation ( CLAR ) from a "Hold" to a "Sell." This was because of ongoing financial pressure that the company had exhibited and concerns about its turnaround prospects. Management even decided to withdraw guidance for 2025 as cash flows turned negative. Management even acknowledged that they were pursuing certain restructuring activities, including rationalizing their SKUs and hiking prices to offset tariffs. Even though revenue for the firm has increased since then, cash flows remain mixed and far from good. This year, it does look as though we might see a bit of improvement on the bottom line compared to what the company saw in 2025. But during the first quarter of the 2026 fiscal year, management even revised lower their expectations on that front. The only good thing about the company is the fact that it has no debt, and it enjoys a cash position of $29.8 million. For a business with a market capitalization of $112.1 million as of this writing, that is certainly substantial. But still, that's not enough for me to upgrade it at this time. Still Right to Be Bearish At its core, Clarus Corporation strikes me as an intriguing prospect. The company operates as a player in the outdoor industry, with an emphasis on producing and selling outdoor equipment and lifestyle products. Many, many years ago, I used to be really active outdoors. I was even a part of the Boy Scouts. But nowadays, it's a rare day that you find me outside my home. Still, for many people, experiencing the great outdoors is a fantastic way to go through life. And it's companies like Clarus Corporation that make this process more enjoyable and accessible than it otherwise would be. Author - SEC EDGAR Data Unfor...
takasuu/iStock via Getty Images Market Overview Global fixed-income markets faced a more challenging backdrop in the first quarter of 2026, as the inflation shock from the Iran War reset monetary policy expectations and shifted government bond yields higher across the curve. Credit spreads* came under pressure as risk premiums widened later in the quarter, though hopes for a ceasefire limited the ...
takasuu/iStock via Getty Images Market Overview Global fixed-income markets faced a more challenging backdrop in the first quarter of 2026, as the inflation shock from the Iran War reset monetary policy expectations and shifted government bond yields higher across the curve. Credit spreads* came under pressure as risk premiums widened later in the quarter, though hopes for a ceasefire limited the extent of the move. Agency mortgage-backed securities outperformed despite elevated rate volatility. Performance Summary Hartford High Yield Fund (I Share)( HAHIX ) underperformed the Bloomberg US Corporate High Yield Bond Index during the quarter. In aggregate, sector allocation had a negative impact on relative performance during the quarter. An overweight to the financial-institutions sector and an underweight to energy detracted from relative results. In contrast, an underweight to the transportation sector and underweight to automotive contributed to relative results. In aggregate, security selection had a negative impact on relative performance during the quarter. From a sector perspective, the largest detractors were security selection within the building materials and the energy industries. In contrast, the largest positive contributors were security selection within media and entertainment and retailers. Positioning & Outlook Conflict erupting in the Middle East paints a more negative picture going into the second quarter. The Federal Reserve and other central banks face an uncertain path as rising energy prices affect economies differently and policy paths diverge. Corporate issuers continue to grapple with trade and geopolitical uncertainty and have curtailed investment and capital expenditures. Fundamentally, issuers maintain healthy profit margins and favorable leverage and coverage ratios relative to long-term averages. However, divergence is emerging across sectors. Capital allocation is increasingly favoring shareholders over creditors, and we expect more le...
Bloomberg Intelligence's Herman Chan joins Dani Burger on "Bloomberg Deals." JPMorgan Chase CEO Jamie Dimon says, “there might be, in the next couple years, a chance to put $10 billion to $20 billion to work buying something,” adding that JPMorgan is “on the lookout” for a deal. (Source: Bloomberg)
Bloomberg Intelligence's Herman Chan joins Dani Burger on "Bloomberg Deals." JPMorgan Chase CEO Jamie Dimon says, “there might be, in the next couple years, a chance to put $10 billion to $20 billion to work buying something,” adding that JPMorgan is “on the lookout” for a deal. (Source: Bloomberg)
Key Points Eli Lilly dominates one of healthcare's fastest-growing markets. Obesity treatments could generate over $100 billion annually. Buy Lilly shares based on fundamentals, not political reasons. 10 stocks we like better than Eli Lilly › President Donald Trump's recent financial disclosures revealed thousands of stock transactions for dozens of companies in the first quarter of 2026, includin...
Key Points Eli Lilly dominates one of healthcare's fastest-growing markets. Obesity treatments could generate over $100 billion annually. Buy Lilly shares based on fundamentals, not political reasons. 10 stocks we like better than Eli Lilly › President Donald Trump's recent financial disclosures revealed thousands of stock transactions for dozens of companies in the first quarter of 2026, including Eli Lilly (NYSE: LLY), one of the biggest winners in the anti-obesity drug boom. The president's stock transactions (or, more likely, transactions made by others on his behalf) may grab headlines, but investors should be careful about copying any politician's trades, particularly after the fact. You should buy stocks based on the attractiveness of the underlying business, not because a public official or celebrity happens to own shares. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » That said, in the case of Eli Lilly, the arguments for ownership remain compelling. An eventual $200 billion market is up for grabs Eli Lilly generated roughly $65 billion in revenue during 2025, driven largely by explosive demand for its diabetes and obesity treatments Mounjaro and Zepbound. Combined sales of those two products exceeded $30 billion last year, making them among the fastest-growing drugs in pharmaceutical history. And the weight-management opportunity still appears to be in its early stages. Analysts at J.P. Morgan and Goldman Sachs have projected that theglobal marketfor anti-obesity drugs could eventually exceed $95 billion annually, with some estimates approaching $200 billion over the next decade. Eli Lilly and Novo Nordisk (NYSE: NVO) currently dominate that market, but Lilly's growth trajectory has recently been stronger as its manufacturing capacity expands and Zepbound continues gaining market share....
Liuhsihsiang/E+ via Getty Images Kennametal ( KMT ) down 6.2% in Wednesday's trading as Barclays downgrades the manufacturer of high-performance cutting tools and engineered components to Underweight from Equal Weight with a $33 price target, cut from $40, saying it expects tungsten prices to decline. Tungsten prices have appreciated very sharply over the long term but are now showing some signs o...
Liuhsihsiang/E+ via Getty Images Kennametal ( KMT ) down 6.2% in Wednesday's trading as Barclays downgrades the manufacturer of high-performance cutting tools and engineered components to Underweight from Equal Weight with a $33 price target, cut from $40, saying it expects tungsten prices to decline. Tungsten prices have appreciated very sharply over the long term but are now showing some signs of fatigue and consolidation, Barclays analyst Julian Mitchell says, noting that tungsten prices historically have performed strongly at times of geopolitical conflict, which suggests that any easing of Iran tensions could accelerate tungsten's price decline. In the event of a drop in the tungsten price, there would be very substantial headline earnings downside risk at Kennametal ( KMT ), Mitchell says, noting the company has not shown an ability to expand operating margins sustainably over the past decade or more without tungsten at least temporarily providing a boost. Kennametal ( KMT ) shares trade at a very high P/E multiple relative to their own history ex-tungsten, the analyst also says, adding that if the stock trades at an ex-tungsten P/E similar to its overall P/E history at ~15x, this would imply a share price of ~$25. More on Kennametal Kennametal Q3 2026 Earnings Call Presentation Kennametal: The Fundamentals Still Aren't Cutting It For Me Kennametal Offers Cyclical Leverage, But The Clock Is Always Ticking
Palantir (PLTR) publicly challenged the Defense Intelligence Agency (DIA) over a program called MARS, the Machine-assisted Analytic Rapid-repository System. The DIA launched this program in 2018 to replace a Cold War-era data analytics system and has been trying to build the new platform largely in-house since then. However, Palantir is saying that the DIA is wasting taxpayer money and violating p...
Palantir (PLTR) publicly challenged the Defense Intelligence Agency (DIA) over a program called MARS, the Machine-assisted Analytic Rapid-repository System. The DIA launched this program in 2018 to replace a Cold War-era data analytics system and has been trying to build the new platform largely in-house since then. However, Palantir is saying that the DIA is wasting taxpayer money and violating procurement law by attempting to rebuild this system from scratch with unreliable results. It wants in on the action. Palantir is demanding the right to bid on modernizing the DIA's core data infrastructure, with the White House siding with Palantir by saying that the Pentagon should use the best private-sector tech available. The Trump admin expects "swift action to remedy this and ensure any company that wants to compete is given a fair chance." Palantir Is Targeting the Intelligence Agencies One trend most investors in Palantir are familiar with is that once this company gets into an agency or an institution, it tends to scale rapidly inside it. If the DIA becomes a Palantir customer, you should expect Palantir to land significant business from it. Palantir already has massive Pentagon business, plus a $10 billion tentative contract it got last year from the Army. The DIA isn't as big as the Army, but if the Pentagon folds, it'll set a precedent for more deals and open more doors for Palantir. If Palantir can optimize and deal with the DIA's operations, the rest of the intelligence community may open up. The DIA is one of 18 intelligence agencies that also face similar data issues, and Palantir could bid to address them. For example, the CIA's venture arm, In-Q-Tel, was an original investor, and Palantir built Gotham with CIA input. If Palantir wins the DIA, it will almost certainly use that as leverage to deepen its CIA footprint for clandestine operations and all-source analysis. A DIA win also gives Palantir a fresh case study to pitch to the NSA or the FBI on replacin...
Palantir (PLTR) publicly challenged the Defense Intelligence Agency (DIA) over a program called MARS, the Machine-assisted Analytic Rapid-repository System. The DIA launched this program in 2018 to replace a Cold War-era data analytics system and has been trying to build the new platform largely in-house since then. However, Palantir is saying that the DIA is wasting taxpayer money and violating p...
Palantir (PLTR) publicly challenged the Defense Intelligence Agency (DIA) over a program called MARS, the Machine-assisted Analytic Rapid-repository System. The DIA launched this program in 2018 to replace a Cold War-era data analytics system and has been trying to build the new platform largely in-house since then. However, Palantir is saying that the DIA is wasting taxpayer money and violating procurement law by attempting to rebuild this system from scratch with unreliable results. It wants in on the action. More News from Barchart Palantir is demanding the right to bid on modernizing the DIA's core data infrastructure, with the White House siding with Palantir by saying that the Pentagon should use the best private-sector tech available. The Trump admin expects "swift action to remedy this and ensure any company that wants to compete is given a fair chance." www.barchart.com Palantir Is Targeting the Intelligence Agencies One trend most investors in Palantir are familiar with is that once this company gets into an agency or an institution, it tends to scale rapidly inside it. If the DIA becomes a Palantir customer, you should expect Palantir to land significant business from it. Palantir already has massive Pentagon business, plus a $10 billion tentative contract it got last year from the Army. The DIA isn't as big as the Army, but if the Pentagon folds, it'll set a precedent for more deals and open more doors for Palantir. If Palantir can optimize and deal with the DIA's operations, the rest of the intelligence community may open up. The DIA is one of 18 intelligence agencies that also face similar data issues, and Palantir could bid to address them. For example, the CIA's venture arm, In-Q-Tel, was an original investor, and Palantir built Gotham with CIA input. If Palantir wins the DIA, it will almost certainly use that as leverage to deepen its CIA footprint for clandestine operations and all-source analysis. A DIA win also gives Palantir a fresh case study t...
SpaceX has won a lucrative contract to provide the US military with a means of distributing space-based sensing and targeting data, forming the "backbone" of a rearchitected network after separate Pentagon initiatives stalled, officials announced Tuesday. Space Systems Command, the Space Force's primary procurement and acquisition center, announced the $2.29 billion firm-fixed-price agreement, con...
SpaceX has won a lucrative contract to provide the US military with a means of distributing space-based sensing and targeting data, forming the "backbone" of a rearchitected network after separate Pentagon initiatives stalled, officials announced Tuesday. Space Systems Command, the Space Force's primary procurement and acquisition center, announced the $2.29 billion firm-fixed-price agreement, confirming long-simmering reports that the Pentagon was likely to tap SpaceX for a new communications network in low-Earth orbit. SpaceX's selection for the Space Data Network (SDN) Backbone contract "accelerates the delivery of a resilient, high-speed communications network in space," Space Systems Command said in a statement. The network will be based on technology originally developed for SpaceX's Starlink global Internet constellation. SpaceX already builds and launches specially designed satellites, called Starshield, for military applications. The SDN Backbone network in low-Earth orbit (LEO) will presumably use the Starshield platform. Read full article Comments
Oracle Corporation has reported fresh quarterly results and highlighted growing momentum in cloud and AI workloads, while the stock continues to trade in the slipstream of the US tech rally. What matters now for investors watching the database and cloud specialist from the United States? Oracle Corporation has recently updated investors on its latest quarterly results, emphasizing accelerating dem...
Oracle Corporation has reported fresh quarterly results and highlighted growing momentum in cloud and AI workloads, while the stock continues to trade in the slipstream of the US tech rally. What matters now for investors watching the database and cloud specialist from the United States? Oracle Corporation has recently updated investors on its latest quarterly results, emphasizing accelerating demand for cloud infrastructure and database services linked to artificial intelligence workloads, while also outlining large customer commitments for future capacity expansions, according to company disclosures and financial media coverage in early June 2024 and September 2024.Oracle investor update as of 06/11/2024 Reuters as of 09/09/2024 In its fiscal fourth quarter 2024, Oracle reported revenue growth driven by cloud services and license support, while some commentators focused on the pace of cloud growth compared with larger rivals and on management’s comments about substantial AI-related contracts that are expected to translate into future revenue streams.Oracle results as of 06/11/2024 As of: 27.05.2026 By the editorial team – specialized in equity coverage. At a glance Name: Oracle Corp Oracle Corp Sector/industry: Enterprise software, databases, cloud infrastructure Enterprise software, databases, cloud infrastructure Headquarters/country: Austin, United States Austin, United States Core markets: Global large enterprises and public sector clients Global large enterprises and public sector clients Key revenue drivers: Cloud services, database software, application software, support contracts Cloud services, database software, application software, support contracts Home exchange/listing venue: New York Stock Exchange (ticker: ORCL) New York Stock Exchange (ticker: ORCL) Trading currency: US dollar (USD) Oracle Corporation: core business model Oracle Corporation is best known as a provider of relational database software and enterprise applications that help organizati...
This article first appeared on GuruFocus. Nvidia (NASDAQ:NVDA) chief Jensen Huang is expected to use his next Taipei stop to reinforce the company's Taiwan supply chain after saying the chipmaker plans to spend about $150 billion a year in Taiwan and build a new headquarters there, Reuters reported. Computex, one of Asia's biggest tech trade shows, runs June 2 to 6 in Taipei. Nvidia's Taiwan push ...
This article first appeared on GuruFocus. Nvidia (NASDAQ:NVDA) chief Jensen Huang is expected to use his next Taipei stop to reinforce the company's Taiwan supply chain after saying the chipmaker plans to spend about $150 billion a year in Taiwan and build a new headquarters there, Reuters reported. Computex, one of Asia's biggest tech trade shows, runs June 2 to 6 in Taipei. Nvidia's Taiwan push matters because TSMC remains the company's key manufacturing partner, while memory suppliers such as SK Hynix help feed demand for Blackwell chips and other AI systems, Huang has said. Reuters also reported that Nvidia's regional headquarters in Taiwan is expected to employ about 4,000 people once it opens. The broader message is that Nvidia is trying to lock in more capacity as AI demand keeps rising and supply chains stay tight. Any fresh signals from Taipei on TSMC, SK Hynix or other partners would likely be watched closely by investors looking for clues about how quickly Nvidia can scale output.